AU2013360026B2 - Methods of treating or preventing respiratory conditions - Google Patents

Methods of treating or preventing respiratory conditions Download PDF

Info

Publication number
AU2013360026B2
AU2013360026B2 AU2013360026A AU2013360026A AU2013360026B2 AU 2013360026 B2 AU2013360026 B2 AU 2013360026B2 AU 2013360026 A AU2013360026 A AU 2013360026A AU 2013360026 A AU2013360026 A AU 2013360026A AU 2013360026 B2 AU2013360026 B2 AU 2013360026B2
Authority
AU
Australia
Prior art keywords
cells
stro
population
asthma
progeny
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2013360026A
Other languages
English (en)
Other versions
AU2013360026A1 (en
Inventor
Peter Ghosh
Silviu Itescu
Ravi Krishnan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mesoblast Inc
Original Assignee
Mesoblast Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mesoblast Inc filed Critical Mesoblast Inc
Publication of AU2013360026A1 publication Critical patent/AU2013360026A1/en
Application granted granted Critical
Publication of AU2013360026B2 publication Critical patent/AU2013360026B2/en
Priority to AU2018226514A priority Critical patent/AU2018226514B2/en
Priority to AU2020202022A priority patent/AU2020202022A1/en
Priority to AU2022209219A priority patent/AU2022209219B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AU2013360026A 2012-12-12 2013-12-12 Methods of treating or preventing respiratory conditions Active AU2013360026B2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2018226514A AU2018226514B2 (en) 2012-12-12 2018-09-10 Methods of treating or preventing respiratory conditions
AU2020202022A AU2020202022A1 (en) 2012-12-12 2020-03-20 Methods of treating or preventing respiratory conditions
AU2022209219A AU2022209219B2 (en) 2012-12-12 2022-07-26 Methods of treating or preventing respiratory conditions

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261736352P 2012-12-12 2012-12-12
US61/736,352 2012-12-12
PCT/AU2013/001454 WO2014089625A1 (en) 2012-12-12 2013-12-12 Methods of treating or preventing respiratory conditions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2018226514A Division AU2018226514B2 (en) 2012-12-12 2018-09-10 Methods of treating or preventing respiratory conditions

Publications (2)

Publication Number Publication Date
AU2013360026A1 AU2013360026A1 (en) 2015-07-02
AU2013360026B2 true AU2013360026B2 (en) 2018-06-21

Family

ID=50933587

Family Applications (4)

Application Number Title Priority Date Filing Date
AU2013360026A Active AU2013360026B2 (en) 2012-12-12 2013-12-12 Methods of treating or preventing respiratory conditions
AU2018226514A Active AU2018226514B2 (en) 2012-12-12 2018-09-10 Methods of treating or preventing respiratory conditions
AU2020202022A Abandoned AU2020202022A1 (en) 2012-12-12 2020-03-20 Methods of treating or preventing respiratory conditions
AU2022209219A Active AU2022209219B2 (en) 2012-12-12 2022-07-26 Methods of treating or preventing respiratory conditions

Family Applications After (3)

Application Number Title Priority Date Filing Date
AU2018226514A Active AU2018226514B2 (en) 2012-12-12 2018-09-10 Methods of treating or preventing respiratory conditions
AU2020202022A Abandoned AU2020202022A1 (en) 2012-12-12 2020-03-20 Methods of treating or preventing respiratory conditions
AU2022209219A Active AU2022209219B2 (en) 2012-12-12 2022-07-26 Methods of treating or preventing respiratory conditions

Country Status (11)

Country Link
US (3) US10028979B2 (cg-RX-API-DMAC7.html)
EP (1) EP2931373B1 (cg-RX-API-DMAC7.html)
JP (5) JP6313327B2 (cg-RX-API-DMAC7.html)
KR (1) KR101748712B1 (cg-RX-API-DMAC7.html)
CN (2) CN115919901A (cg-RX-API-DMAC7.html)
AU (4) AU2013360026B2 (cg-RX-API-DMAC7.html)
CA (1) CA2893951C (cg-RX-API-DMAC7.html)
ES (1) ES2759281T3 (cg-RX-API-DMAC7.html)
IL (1) IL239309A0 (cg-RX-API-DMAC7.html)
SG (2) SG11201504352TA (cg-RX-API-DMAC7.html)
WO (1) WO2014089625A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115919901A (zh) 2012-12-12 2023-04-07 麦瑟布莱斯特公司 治疗或预防呼吸病症的方法
US20170296589A1 (en) * 2014-09-23 2017-10-19 Case Western Reserve University Compositions and methods for treating lung remodeling diseases
JP2020533373A (ja) * 2017-09-15 2020-11-19 サイナータ セラピューティクス リミテッド アレルギー性気道疾患（ａａｄ）／喘息の処置方法
TW202146033A (zh) * 2020-01-30 2021-12-16 日商Ｊｃｒ製藥股份有限公司 包含源自牙髓的細胞之醫藥組成物
JP7551341B2 (ja) * 2020-06-04 2024-09-17 株式会社三共 遊技機
JP7551340B2 (ja) * 2020-06-04 2024-09-17 株式会社三共 遊技機
CN118800458B (zh) * 2024-09-14 2024-11-15 吉林大学 一种心胸外科术后并发症预测方法及系统

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004084921A1 (en) * 2003-03-28 2004-10-07 Angioblast Systems Incorporated Perivascular mesenchymal precursor cell induced blood vessel formation
WO2008036374A2 (en) * 2006-09-21 2008-03-27 Medistem Laboratories, Inc. Allogeneic stem cell transplants in non-conditioned recipients
US20090053182A1 (en) * 2007-05-25 2009-02-26 Medistem Laboratories, Inc. Endometrial stem cells and methods of making and using same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050118714A1 (en) * 2002-02-19 2005-06-02 Chul-Won Ha Isolation and culture-expansion methods of mesenchymal stem/progenitor cells from umbilical cord blood and differentation method of umbilical cord blood-derived mesenchymal stem/progenitor cells into various mesenchymal tissues
US20080095749A1 (en) * 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
CN102391981B (zh) * 2004-09-24 2014-08-20 麦索布莱斯特公司 多能扩增间充质前体细胞子代(memp)及其应用
WO2006108229A1 (en) * 2005-04-12 2006-10-19 Angioblast Systems, Inc. Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase
ES2923016T3 (es) * 2007-08-06 2022-09-22 Mesoblast Inc Células precursoras mesenquimales TNAP+ para el tratamiento de enfermedades del tejido conectivo
JP5539886B2 (ja) * 2007-10-17 2014-07-02 ティクセル Ｔｒ１細胞、間葉系幹細胞およびその使用
US8828375B2 (en) * 2008-09-03 2014-09-09 Mesoblast, Inc. Expansion of haemopoietic precursors
AU2011274255B2 (en) * 2010-07-02 2016-05-05 Mesoblast, Inc. Treatment of T-cell mediated immune disorders
KR101947699B1 (ko) * 2011-03-11 2019-02-14 칠드런'즈 메디컬 센터 코포레이션 중간엽 줄기 세포 엑소솜에 관련된 방법 및 조성물
CA2837895C (en) * 2011-06-03 2021-07-27 Mesoblast, Inc. Methods of treating or preventing neurological diseases
CN115919901A (zh) 2012-12-12 2023-04-07 麦瑟布莱斯特公司 治疗或预防呼吸病症的方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004084921A1 (en) * 2003-03-28 2004-10-07 Angioblast Systems Incorporated Perivascular mesenchymal precursor cell induced blood vessel formation
WO2008036374A2 (en) * 2006-09-21 2008-03-27 Medistem Laboratories, Inc. Allogeneic stem cell transplants in non-conditioned recipients
US20090053182A1 (en) * 2007-05-25 2009-02-26 Medistem Laboratories, Inc. Endometrial stem cells and methods of making and using same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BONFIELD ET AL., "Human mesenchymal stem cells suppress chronic airway inflammation in the murine ovalbumin asthma model.", AM J PHYSIOL LUNG CELL MOL PHYSIOL, (2010), vol. 299, pages L760 - L770 *

Also Published As

Publication number Publication date
US20150306146A1 (en) 2015-10-29
US20200289578A1 (en) 2020-09-17
US10688134B2 (en) 2020-06-23
AU2018226514B2 (en) 2020-01-02
EP2931373B1 (en) 2019-08-21
JP2018118987A (ja) 2018-08-02
CA2893951C (en) 2022-05-03
KR20150090237A (ko) 2015-08-05
AU2013360026A1 (en) 2015-07-02
JP2016502980A (ja) 2016-02-01
AU2018226514A1 (en) 2018-09-27
JP2024041904A (ja) 2024-03-27
JP6313327B2 (ja) 2018-04-18
KR101748712B1 (ko) 2017-06-19
US20190046575A1 (en) 2019-02-14
AU2022209219A1 (en) 2022-08-18
JP6665218B2 (ja) 2020-03-13
JP7420844B2 (ja) 2024-01-23
AU2020202022A1 (en) 2020-04-09
HK1210077A1 (en) 2016-04-15
WO2014089625A1 (en) 2014-06-19
SG10201807682PA (en) 2018-10-30
AU2022209219B2 (en) 2025-08-14
EP2931373A1 (en) 2015-10-21
EP2931373A4 (en) 2016-05-04
SG11201504352TA (en) 2015-07-30
IL239309A0 (en) 2015-07-30
CA2893951A1 (en) 2014-06-19
CN105377274A (zh) 2016-03-02
ES2759281T3 (es) 2020-05-08
US10028979B2 (en) 2018-07-24
JP2020097618A (ja) 2020-06-25
JP2022065132A (ja) 2022-04-26
CN115919901A (zh) 2023-04-07

Similar Documents

Publication Publication Date Title
US10688134B2 (en) Methods of treating or preventing respiratory conditions
US20190201448A1 (en) Methods of treating or preventing neurological diseases
AU2019202960A1 (en) Treatment of diseases of endothelial dysfunction and inflammation
AU2016247132B2 (en) Methods for treating obesity and/or metabolic syndrome
US20240024366A1 (en) Methods of treating or preventing respiratory conditions
HK1210077B (en) Methods of treating or preventing respiratory conditions
HK1210209B (en) Treatment of diseases of endothelial dysfunction and inflammation
HK40014520A (en) Treatment of diseases of endothelial dysfunction and inflammation

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)